Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PSB-0739

🥰Excellent
Catalog No. T23195Cas No. 1052087-90-7
Alias PSB0739

PSB-0739 Selective platelet P2Y12 receptor antagonist characterized by competitive binding and high affinity (Ki =24.9 nM) with antithrombotic and platelet aggregation modulating effects.

PSB-0739

PSB-0739

🥰Excellent
Catalog No. T23195Alias PSB0739Cas No. 1052087-90-7
PSB-0739 Selective platelet P2Y12 receptor antagonist characterized by competitive binding and high affinity (Ki =24.9 nM) with antithrombotic and platelet aggregation modulating effects.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More
Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PSB-0739 Selective platelet P2Y12 receptor antagonist characterized by competitive binding and high affinity (Ki =24.9 nM) with antithrombotic and platelet aggregation modulating effects.
Targets&IC50
HIV-1 infection enhanced by SEVI:21.77  μM
In vitro
PSB-0739 inhibits the formation of semen-derived amyloid fibrils (SEVI), which enhance HIV-1 infection. It demonstrates direct anti-HIV activity with an IC₅₀ of 21.77 ± 5.15 μM, without significant cytotoxicity in HeLa cells at concentrations below 62.5 μM[1].
In vivo
In rat models, PSB-0739 administered intrathecally (0.01–0.3 mg/kg) significantly reduced CFA-induced inflammatory pain and sciatic nerve ligation-induced neuropathic pain, with a minimal effective dose of 0.1 mg/kg. It also increased pain thresholds in the hot plate test, indicating analgesic effects. Additionally, PSB-0739 decreased the expression of pro-inflammatory cytokines such as IL-1β and TNF-α in inflamed tissues (paw and spinal cord), suggesting its mechanism involves inhibition of cytokine signaling both centrally and peripherally[2].
AliasPSB0739
Chemical Properties
Molecular Weight609.54
FormulaC26H17N3Na2O8S2
Cas No.1052087-90-7
SmilesO=C1C2=C(C(C3=C(NC4=CC=C(C(S(=O)([O-])=O)=C4)NC5=CC=CC=C5)C=C(S(=O)([O-])=O)C(N)=C13)=O)C=CC=C2.[Na+].[Na+]
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 1.00 mg/mL (1.64 mM), Sonication is recommended.
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM1.6406 mL8.2029 mL16.4058 mL82.0291 mL

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PSB-0739 | purchase PSB-0739 | PSB-0739 cost | order PSB-0739 | PSB-0739 chemical structure | PSB-0739 in vivo | PSB-0739 in vitro | PSB-0739 formula | PSB-0739 molecular weight